An Indiana CDMO with big-name clients sets up plans for lentiviral production site

An Indiana CDMO focused on gene therapy is cashing in on the industry’s hot streak and unveiling a master plan for a 75,000-square-foot lentiviral vector production site.

Genezen Laboratories broke ground on the construction of a new plant outside Indianapolis, IN. It will complete the first phase of construction —...

Click to view original post